Earth Life Sciences Inc.
CLTS · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6,309 | $10,155 | $7,780 | $3,166 |
| - Cash | -$47 | $0 | $0 | $0 |
| + Debt | $268 | $264 | $299 | $294 |
| Enterprise Value | $6,624 | $10,420 | $8,079 | $3,460 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$21 | -$322 | -$36 | -$18 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | 92.8% | -705% | 0.3% | – |
| Operating Cash Flow | $799,999 | -$4 | -$1 | $19 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $799,999 | -$4 | -$1 | $19 |